"synopsis" may belong to another edition of this title.
Karen Nagel is an Associate Professor of Pharmaceutics at Midwestern University Chicago College of Pharmacy where she has worked since 1999. She received her Ph.D in Industrial and Physical Pharmacy from Purdue University. Her current teaching responsibilities include required and elective courses in compounding, dosage form design, biotechnology, and the history of pharmacy. In order to increase their knowledge of and interest in careers in academia, she precepts several academic APPE rotation students per year.
Dr. Nagel’s primary areas of research are herbal product analysis and pharmaceutical compounding. She also has interests in biotechnology, dosage form design and educational research, and has contributed to several textbooks, review guides and encyclopedias.
Dr. Nagel has been a member of AAPS since 1994 and has served on the planning committee of the local chapter, the Chicagoland Pharmaceutics Discussion Group, since 2002 (Treasurer, 2002-04; Chair, 2005-06). Dr. Nagel is a past chair (2010-11) of the APhA APRS Basic Sciences section, and has served on the APRS Awards, Education, and Policy committees. She has also been a member of AACP since 1999, serving as secretary of the Teachers of Pharmaceutics section (TOPS) from 2005-7 and as chair of the Laboratory SIG from 2004-5. She has served as an abstract and grant reviewer for AACP and APhA, and has moderated sessions at annual meetings for both groups. She also has served on the NABP Foreign Pharmacy Equivalency Exam Review Committee since 2003. Dr. Nagel serves on numerous college and university committees and is faculty advisor to the Midwestern University AAPS Student Chapter."About this title" may belong to another edition of this title.
Book Description Soft Cover. Condition: new. Seller Inventory # 9783030074920
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783030074920_lsuk
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020004776
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783030074920
Book Description Condition: New. Book is in NEW condition. 0.45. Seller Inventory # 3030074927-2-1
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis,will deal only with peptides, proteins and monoclonal antibodies. 124 pp. Englisch. Seller Inventory # 9783030074920
Book Description Condition: New. Seller Inventory # I-9783030074920
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Concise Introduction to development and analysis of pharmaceutical biologicsFocuses on peptides, proteins and monoclonal antibodiesWritten for industries switching from small molecules to biologicsKaren Nagel is an Associate Professor of . Seller Inventory # 448670713
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis,will deal only with peptides, proteins and monoclonal antibodies. Seller Inventory # 9783030074920
Book Description Condition: New. 2019. Softcover reprint of the original 1st ed. 2018. paperback. . . . . . Seller Inventory # V9783030074920